EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review

Caroline B Terwee, Petra J M Elders, Marieke T Blom, Joline W Beulens, Olaf Rolandsson, Alize A Rogge, Matthias Rose, Nicola Harman, Paula R Williamson, Frans Pouwer, Lidwine B Mokkink, Femke Rutters

Diabetologia · 2023-08 · 66 (8) · 1357-1377

DOI: 10.1007/s00125-023-05926-3 ↗

At a glance

Übersichtsarbeit in Diabetologia, published online on 2023-05-24. Written by Caroline B Terwee and 11 co-authors. Institution: Amsterdam UMC, Department of Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. cb.terwee@amsterdamumc.nl. Major MEDLINE topics: Quality of Life, Diabetes Mellitus. Cited 49 times so far (Crossref); 171 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Federations for the Study of Diabetes, Diabetes Foundation Netherlands.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Patient-reported outcomes (PROs) are valuable for shared decision making and research. Patient-reported outcome measures (PROMs) are questionnaires used to measure PROs, such as health-related quality of life (HRQL). Although core outcome sets for trials and clinical practice have been developed separately, they, as well as other initiatives, recommend different PROs and PROMs. In research and clinical practice, different PROMs are used (some generic, some disease-specific), which measure many different things. This is a threat to the validity of research and clinical findings in the field of diabetes. In this narrative review, we aim to provide recommendations for the selection of relevant PROs and psychometrically sound PROMs for people with diabetes for use in clinical practice and research. Based on a general conceptual framework of PROs, we suggest that relevant PROs to measure in people with diabetes are: disease-specific symptoms (e.g. worries about hypoglycaemia and diabetes distress), general symptoms (e.g. fatigue and depression), functional status, general health perceptions and overall quality of life. Generic PROMs such as the 36-Item Short Form Health Survey (SF-36), WHO Disability Assessment Schedule (WHODAS 2.0), or Patient-Reported Outcomes Measurement Information System (PROMIS) measures could be considered to measure commonly relevant PROs, supplemented with disease-specific PROMs where needed. However, none of the existing diabetes-specific PROM scales has been sufficiently validated, although the Diabetes Symptom Self-Care Inventory (DSSCI) for measuring diabetes-specific symptoms and the Diabetes Distress Scale (DDS) and Problem Areas in Diabetes (PAID) for measuring distress showed sufficient content validity. Standardisation and use of relevant PROs and psychometrically sound PROMs can help inform people with diabetes about the expected course of disease and treatment, for shared decision making, to monitor outcomes and to improve healthcare. We recommend further validation studies of diabetes-specific PROMs that have sufficient content validity for measuring disease-specific symptoms and consider generic item banks developed based on item response theory for measuring commonly relevant PROs. Graphical Abstract

Subjects

MeSH terms (MEDLINE)

Quality of LifeDiabetes MellitusHumansPatient Reported Outcome MeasuresSurveys and QuestionnairesHealth Surveys

Author keywords

DiabetesPatient-reported outcomePatient-reported outcome measureReviewStandardisation

Authors and institutions

  • Amsterdam UMC, Department of Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. cb.terwee@amsterdamumc.nl.
  • Amsterdam Public Health Research Institute, Methodology, Amsterdam, the Netherlands. cb.terwee@amsterdamumc.nl.
  • Amsterdam Public Health Research Institute, Methodology, Amsterdam, the Netherlands.
  • Amsterdam UMC, Department of General Practice, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Amsterdam UMC, Department of Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, Umeå, Sweden.

Funding

  • European Federations for the Study of Diabetes
  • Diabetes Foundation Netherlands

Cite

APA

Terwee, C. B., Elders, P. J. M., Blom, M. T., Beulens, J. W., Rolandsson, O., Rogge, A. A., Rose, M., Harman, N., Williamson, P. R., Pouwer, F., Mokkink, L. B., & Rutters, F. (2023). Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review. Diabetologia, 66(8), 1357-1377. https://doi.org/10.1007/s00125-023-05926-3

Vancouver

Terwee CB, Elders PJM, Blom MT, Beulens JW, Rolandsson O, Rogge AA, et al. Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review. Diabetologia. 2023;66(8):1357-1377. doi:10.1007/s00125-023-05926-3

BibTeX
@article{Terwee2023,
  author = {Terwee, Caroline B and Elders, Petra J M and Blom, Marieke T and Beulens, Joline W and Rolandsson, Olaf and Rogge, Alize A and Rose, Matthias and Harman, Nicola and Williamson, Paula R and Pouwer, Frans and Mokkink, Lidwine B and Rutters, Femke},
  title = {Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review},
  journal = {Diabetologia},
  year = {2023},
  volume = {66},
  number = {8},
  pages = {1357--1377},
  doi = {10.1007/s00125-023-05926-3}
}
Start for free →